Roswell Biotechnologies
Carl has been working for more than 30 years with DNA polymerases, RNA polymerases, and reverse transcriptases. He was directly involved in corporate efforts to produce complete sequencing systems such as the capillary electrophoresis system of Molecular Dynamics/Amersham, the SOLiD system of Applied Biosystems, and the chip-based sequencers of Genia and Ion Torrent. Carl has served in senior and executive-level positions at Singular Genomics, Genia Technologies (now Roche), Life Technologies, GE Healthcare, and Amersham Biosciences. He has published over 70 issued patents and patent applications.
This person is not in any teams
This person is not in any offices
Roswell Biotechnologies
Roswell Biotechnologies is digitizing biology through molecular electronics to elucidate, diagnose and treat disease. The company has developed the world's first molecular electronics chip, the Roswell ME Chip, by integrating single molecules into standard semiconductor chip technology to deliver a powerful biosensor that converges all omics on one platform.